Aug. 28, 2012
/PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that the Company's Chief Executive Officer,
Brian M. Culley
, will present at the Rodman & Renshaw Annual Global Investment Conference on
Monday, September 10, 2012
2:25 p.m. Eastern time
, in the Starlight Center Salon at The Waldorf Astoria hotel in
New York City
Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals web site at
. An archived presentation will be available on the web site for 30 days.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical company developing proprietary product candidates to treat various diseases and conditions. The Company's lead product candidate, ANX-188, has potential to reduce ischemic tissue injury and end-organ damage by restoring microvascular function which is compromised in a wide range of serious and life-threatening diseases and conditions. The Company initially is developing ANX-188 as a treatment for complications arising from sickle cell disease. More information can be found on the Company's web site at
SOURCE ADVENTRX Pharmaceuticals, Inc.